Dr Nicholas Turner is a consultant medical oncologist at The Royal Marsden Hospital, London, who specialises in the treatment of breast cancer. Dr Nicholas Turner studied natural sciences at Cambridge University before qualifying in 1997 from the University of Oxford Medical School with his medical degree. After completing general medical training in London, he trained in medical oncology at the Royal Free and University College Hospitals, London. He completed a PhD at The Institute of Cancer Research in 2006 before joining the Breast Unit of The Royal Marsden Hospital in 2008.
Dr Nicholas Turner is a team leader in molecular oncology at the Breast Cancer Now Research Centre at the Institute of Cancer Research, London. He is also the breast theme lead for The Royal Marsden National Institute for Health Research Biomedical Research Centre, and a member of the National Cancer Research Institute Breast Cancer Clinical Studies Group. In addition, he is the breast domain lead of the Genomics England Clinical Interpretation Partnerships. His research interests include the development of new therapies for breast cancer and using liquid biopsies to deliver more precise treatment for breast cancer.
Dr Nicholas Turner is chief investigator of several national and international trials of precision therapy in breast cancer. He sits on the organising committees of many international conferences on breast cancer, and was previously the executive chair of the IMPAKT 2015 breast cancer conference. He is a scientific editor of the journal Cancer Discovery.